The role of prostaglandins (PGs) in embryo hatching remains controversial. In addition, there is no direct evidence that mouse embryos synthesize PGs. METHODS: The effects of endogenous PG on mouse embryo hatching were evaluated by blocking endogenous PG synthesis with indomethacin. Specific cyclooxygenase (COX) inhibitors were used to identify the role of COX-1-and COX-2-derived PGs. An eicosanoid profile was generated by incubating blastocysts with [ 3 H]arachidonic acid and analysing the metabolites by high performance liquid chromatography. The expression and the localization of COX-1, COX-2 and prostacyclin synthase (PGIS) were examined by western blot analysis and immunohistochemistry. RESULTS: The hatching of embryos cultured in 30 ml of protein-free medium was blocked by indomethacin (P 5 0.007) or a selective COX-2 inhibitor (P 5 0.004). Adding back iloprost, a prostacyclin analogue, abolished the effects of the COX-2 inhibitor. Prostacyclin was the most abundant PG produced by mouse blastocysts, which expressed COX
Introduction
A receptive endometrium is indispensable to a successful implantation. The critical role of endometrium-derived prostaglandins (PGs) in implantation is underscored by the failure of embryo reception in cyclooxygenase-2 (COX-2) gene knockout mice and its partial restoration by exogenous prostacyclin (PGI 2 ) (Lim et al., 1999) . Complete hatching of embryos is a pre-requisite for successful implantation (Hartshorne and Edwards, 1991) . The role of embryoderived, endogenous PGs and embryo hatching remains controversial. Earlier studies showed that 10 mmol/l of indomethacin, one of the non-selective COX-1 and COX-2 inhibitors, blocked mouse embryo hatching in vitro (Biggers et al., 1978; Hurst and MacFarlane, 1981) . More recent studies suggested that a much higher concentration of indomethacin (, 100 mmol/l) was required to inhibit the hatching of cultured mouse embryos (Chida et al., 1986; van der Weiden et al., 1993) .
Blastocysts from farm animals such as cattle and sheep produce PGs; blastocysts from rabbits also produce PGs (reviewed by Lewis et al., 1989) . Although PG production by mouse embryos was suggested by some studies, the direct evidence is lacking. Mouse embryos express COX mRNA (Takami et al., 1994) and display immunoreactive COX (van der Weiden et al., 1996) . In addition, PGE 2 was detected immunohistochemically in mouse embryos (Niimura and Ishida, 1987) . The exact eicosanoid profile, especially PGI 2 production by mouse embryos, has not been reported. Furthermore, the role of embryo-derived eicosanoids in embryo hatching is unclear.
In this study, we determined eicosanoid production by mouse embryos and evaluated the role of PGI 2 in embryo hatching. Our results confirmed earlier reports that 10 mmol/l of indomethacin inhibited mouse embryo hatching. Furthermore, using selective COX-1 and COX-2 inhibitors, we discovered that embryo hatching was suppressed selectively by COX-2 inhibitor and that adding back a PGI 2 analogue abolished the effects of the COX-2 inhibitor. Analysis of eicosanoids by reverse phase high performance liquid chromatography (HPLC) revealed that mouse embryos synthesized predominantly PGI 2 from exogenous arachidonic acid (AA). Western blot analysis showed that COX-1, COX-2 and PGI 2 synthase (PGIS) proteins were expressed by mouse blastocysts. We concluded that COX-2-derived PGI 2 enhanced embryo hatching.
Materials and methods
Unless stated otherwise, reagents were purchased from Sigma Co. (St Louis, MO).
Harvest and culture of mouse embryos
The care and the manipulation of mice were consistent with the Guide for the Care and Use of Laboratory Animals published by the US National Institute for Health (NIH publication No. 85-23, revised 1996) . The research protocol was approved by the Animal Welfare Committee of the University of Texas Health Science Center-Houston.
Mouse embryos were harvested and cultured as described previously (Huang et al., 2003) with some modifications. Threeweek-old C57Bl/6 female mice were purchased from Harlan (Indianapolis, IN) and 8-week-old C3H male mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Superovulation in the female mice was achieved by i.p. injection of pregnant mare's serum gonadotrophin (5 IU), followed by HCG (5 IU) 46 h later. After receiving HCG, each female mouse was paired with one fertile male mouse. Forty-eight hours later, 2-cell embryos were harvested from the oviducts into a-minimum essential medium (MEM) supplemented with 25 mmol/l HEPES and 1% bovine serum albumin (BSA) (Irvine Scientific, Santa Ana, CA).
Embryos (17 -20 per group) were cultured at 378C under 5% CO 2 in 3 cm plates containing 30 ml droplets of protein-free medium under oil (see next paragraph). Human tubal fluid medium (Sage Biopharma, Bedminster, NJ) was used during the first 48 h and a-MEM, with Earle's salts and 2 mmol/l glutamine, was used during the second 48 h. After 96 h culture, each embryo was examined for the presence of the zona pellucida. Embryos completely free of the zona pellucida were counted as having completely hatched. The rate of complete hatching was determined by dividing the number of completely hatched embryos by the total number of embryos. Complete embryo hatching was chosen as the end-point because it correlates with the establishment of a viable pregnancy .
Using 30 ml of culture medium per 17 -20 embryos was designed to reveal the autocrine/paracrine effects of embryo-derived factors. A similar approach was used previously to show the autocrine effects of embryo-derived transforming growth factor-b (Brison and Schultz, 1997) and platelet-activating factor (Lu et al., 2004) . We confirmed in our preliminary studies that embryos cultured in 30 ml of protein-free medium were optimal for our experiments as they had a significantly higher rate of complete hatching (48%) compared with those cultured in 600 ml of medium with or without protein supplement (30 and 27%, respectively).
Western blot analysis
Monoclonal antibody for COX-1, affinity-purified polyclonal peptide antibody for COX-2 (both from Cayman Chemical, Ann Arbor, MI) and affinity-purified polyclonal peptide antibody for PGIS (a gift from Dr Ke-He Ruan, The University of Texas Health Science Center) were used to detect the respective protein in the total cell lysate of mouse blastocysts. Details of the western blot analysis are described in the accompanying manuscript.
The total cell lysate of blastocysts was prepared as follows. Mouse blastocysts in 2 ml of medium were transferred to 1.5 ml Eppendorf tubes containing 30 ml of lysis buffer (150 mmol/l NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mmol/l sodium orthovanadate, 1 mmol/l EGTA and 1 mmol/l sodium fluoride) and protease inhibitors [1 mmol/l 4-(2-aminoethyl) benzene sulphonyl fluoride hydrochloride, 0.8 mmol/l aprotinin, 50 mmol/l betastatin, 15 mmol/l E-64, 20 mmol/l leupeptin hemisulphate, 10 mmol/l pepstatin A, Calbiochem-Novabiochem Corp., San Diego, CA]. The mixture was vortexed for 5 s, centrifuged for 10 s and stirred on ice for 30 min. After two bursts of sonication (Sonifier 250, Branson Co. Danbury, CT), of 1 s each, the protein loading buffer (4 £ ) was added. Afterwards, the supernatant was used for western blot analysis. Lysates from 26, 75 and 67 mouse blastocysts were used for COX-1, COX-2 and PGIS detection, respectively.
Eicosanoid profile The metabolites of [
3 H]AA generated by mouse embryos were analysed by a reverse phase HPLC based on a procedure described previously (Sanduja et al., 1991) . Briefly, 200 mouse blastocysts were incubated in 100 ml of a-MEM containing 20 mmol/l [ 3 H]AA (150 -240 Ci/mmol, ICN Biochemicals, Inc., Irvine, CA) in a 378C water bath for 30 min. After extraction, the eicosanoids were separated and identified using HPLC as described in the accompanying manuscript. To confirm the identity of a peak, an equal amount of the standard was co-injected with the sample and a doubling in the height of the peak was observed.
Immunohistochemistry and fluorescence microscopy Affinity-purified COX-1 and COX-2 polyclonal antibodies conjugated with rhodamine (Santa Cruz Biotechnology Inc., Santa Cruz, CA) were used to localize COX-1 and COX-2 in the mouse embryos. The affinity-purified polyclonal PGIS antibody (used in the western blot analysis) and a goat anti-rabbit immunoglobulin G (IgG) antibody coupled with Alexa 488 (Molecular Probes, Eugene, OR) were used to detect PGIS in the mouse embryos. The embryos were first fixed in 4% paraformaldehyde (pH7.4) at 48C for 30 min. After three washes in phosphate-buffered saline (PBS), the embryos were blocked in Tris-buffered saline (pH7.4) containing 0.05% Tween-20, 5% powder milk and 0.1% Triton X-100 for 20 min at room temperature. The embryos were incubated at 378C with the respective antibody in blocking buffer for 2 h. In the case of PGIS, there was an additional incubation with goat anti-rabbit IgG coupled with Alexa 488 (0.625 mg/ml) for 30 min at 378C. Finally, the embryos were mounted in 0.1 mol/l Tris -HCl (pH8.5) containing 16.6% Elvanol 50-42 (DuPont Wilmington, DE) and 2.5% 1,4-diazabicyclo-(2.2.2)-octane. An equal concentration of non-immune rabbit IgG conjugated with fluorescein isothiocyanate (Santa Cruz Biotechnology) in place of conjugated COX-1 and COX-2 antibody was used as negative controls for COX-1 and COX-2, respectively; an equal concentration of pre-absorbed PGIS antibody was used as negative control for PGIS.
Fluorescence microscopy was performed using a Zeiss AxioPlan 2 microscope (Carl Zeiss, Baden-Wuerttemberg, Germany) equipped with appropriate filters. Images were captured using a CCD camera and processed by the AxioVision program (Version 3.0.6).
Statistical analysis
Student's t-test or one-way analysis of variance followed by the indicated post hoc tests was used. P , 0.05 was considered statistically significant. The analysis was performed using the InStat w software (GraphPad Prism Software Inc., San Diego, CA).
Endogenous PGI 2 enhances embryo hatching
Results

Indomethacin and a selective COX-2 inhibitor blocked embryo hatching
To evaluate the effects of indomethacin on embryo hatching, we cultured embryos (17 -20 embryos per group) in 30 ml of protein-free medium for 96 h. Indomethacin significantly reduced the percentage of completely hatched embryos (Figure 1 ), consistent with an important role for COX metabolites in embryo hatching. Since indomethacin nonselectively inhibits COX-1 and COX-2 activities, we next investigated the influence of selective COX-1 and COX-2 inhibitors on embryo hatching. SC-58125, a selective COX-2 inhibitor, blocked embryo hatching to an extent comparable with indomethacin, whereas SC-560, a selective COX-1 inhibitor, had no effect (Figure 2 ). Taken together, these results suggest that COX-2-derived prostanoids are involved in embryo hatching.
Iloprost but not PGE 2 or PGF 2a analogue restored embryo hatching
To identify the prostanoid involved in embryo hatching, we added back iloprost (a stable analogue of PGI 2 ), PGE 2 and fluprostenol (a stable analogue of PGF 2a ) to embryos cultured with selective COX-2 inhibitor (SC 58125) in 30 ml of protein-free medium. The results show that the inhibition of hatching by SC 58125 was reversed by iloprost but not by PGE 2 or fluprostenol. Interestingly, embryos receiving iloprost add-back appeared to have a higher percentage of completely hatched embryos than those embryos without the inhibitor treatment (Figure 3 ).
Mouse blastocysts produced PGI 2 and expressed COX-1, COX-2 and PGIS Since the exogenously added iloprost restored the hatching blocked by SC 58125, we wondered whether embryos synthesized PGI 2 . We analysed eicosanoids by reversed phase HPLC. Blastocysts were incubated in a-MEM containing [
3 H]AA for 30 min, the medium was collected and eicosanoids in the medium were extracted and analysed by HPLC. 6-Keto-PGF 1a , a stable metabolite of PGI 2 , was the major Figure 1 . Indomethacin blocked complete embryo hatching. Twocell embryos (17 -20 per group) were cultured in 30 ml of proteinfree medium with or without indomethacin (10 mmol/l). After 96 h, the rate of complete hatching was determined. Indomethacin reduced the rate of complete hatching. The data represent the mean^SD of 13 and three independent observations on control embryos and embryos receiving indomethacin, respectively (*P ¼ 0.007). were cultured for 96 h in 30 ml of protein-free medium with 1 mmol/l of specific COX-1 (SC 560) or COX-2 (SC 58125) inhibitors. SC 58125 significantly reduced the rate of complete hatching. The data represent the mean^SD of compete hatching of 11, four and six independent observations on control embryos and embryos receiving SC 560 and SC 58125, respectively (P ¼ 0.004, one-way ANOVA; *P , 0.01 based on Dunnett's test). Figure 3 . Iloprost, a prostacyclin (PGI 2 ) analogue, restored the enhanced hatching abolished by COX-2 inhibitor. Two-cell embryos (17 -20 per group) were cultured in 30 ml of protein-free medium with selective COX-2 inhibitor (SC 58125) or prostaglandin (or its analogue) where indicated. The rates of complete hatching were determined 96 h later. Compared with embryos cultured with the inhibitor, those cultured without the inhibitor or receiving iloprost add-back had significantly higher rates of complete hatching. The data represent the mean^SD of complete hatching (%) based on eight observations on embryos with the inhibitor, 13 observations on embryos cultured without the inhibitor, five observations on embryos with iloprost add-back and three each observations on PGE 2 and fluprotenol add-back (P ¼ 0.0013, one-way ANOVA; *P , 0.01). product, whereas PGE 2 and PGF 2a were detected in relatively small quantities (Figure 4 ). To confirm that mouse blastocysts possess the enzymatic machinery to synthesize PGI 2 , we homogenized blastocysts and determined COX-1, COX-2 and PGIS proteins in the cell lysate by western blot analysis. COX-1, COX-2 and PGIS proteins were detected ( Figure 5 ).
Developmental stage-specific expression of COX-1, COX-2 and PGIS in mouse embryos
The developmental stage-specific expression of COX-1, COX-2 and PGIS and their localization in the mouse embryos were examined by immunohistochemistry. Direct immunohistochemistry was used for the detection and the localization of COX-1 and COX-2; indirect immunohistochemistry was used for the detection and the localization of PGIS. Our results show that COX-1 became detectable in 8-cell and later stage embryos and that COX-2 and PGIS became detectable in 4-cell and later stage embryos ( Figure 6 ). Cellular localization analysis shows that all three enzymes were expressed in the trophectoderm and the inner cell mass of the blastocysts.
Discussion
We provide direct evidence, for the first time, for the synthesis of PGs by mouse blastocysts. We further demonstrate that mouse blastocysts synthesized abundant PGI 2 , which enhances complete hatching. The eicosanoid profile of blastocysts appears to be species specific. Our data reveal that mouse embryos produce, in order of abundance, PGI 2 , PGE 2 and PGF 2a . In this respect, mouse embryos are similar to sheep embryos which produce mainly PGI 2 and PGF 2a , but different from cattle and pig blastocysts which produce mostly PGF 2a and PGE 2 , respectively (Lewis et al., 1989) .
Our results confirmed earlier reports by Biggers et al. (1978) and Hurst and MacFarlane (1981) that indomethacin at a therapeutic concentration (, 10 mmol/l) inhibited embryo hatching. The discrepancy between the aforementioned reports and the more recent reports by van der Weiden et al. (1993) and Chida et al. (1986) , which indicated that , 100 mmol/l indomethacin was required to inhibit embryo hatching, may be attributable to the protein in the medium. Rat serum (30 mg/ml) and BSA (5 mg/ml) were used in the studies by van der Weiden and Chida, respectively, whereas protein-free medium was used in earlier studies. 3 H]arachidonic acid. The medium was collected, eicosanoids extracted and analysed by HPLC. (I denotes 6 keto PGF 1a , the stable metabolite of PGI 2 ; E, PGE 2 ; F, PGF 2a ; HHT, heptadecatrienoic acid; HETE, hydroxyeicosatetraenoic acid; AA, arachidonic acid.) Figure 5 . Mouse embryos expressed both COX isoforms and prostacyclin synthase (PGIS). Total cell lysates of mouse blastocysts were subject to western blot analysis to detect COX-1, COX-2 and PGIS. The respective affinity-purified antibodies were used for the detection and an enhanced chemifluorescence was used for visualization. Purified COX-1 from sheep seminal vesicles, recombinant human COX-2 and recombinant human PGIS were used as positive controls. Lanes 1, 3 and 5 are positive controls; lanes 2, 4 and 6 are the cell lysates of mouse embryos probed with the respective antibody.
Endogenous PGI 2 enhances embryo hatching Our data are in agreement with those of previous reports that indomethacin at 10 mmol/l inhibited embryo hatching by , 40-50% (Biggers et al., 1978; Hurst and MacFarlane, 1981) . Prior to this study, it was unclear how indomethacin inhibits embryo hatching. Results from this study indicate that the inhibitory action of indomethacin was attributable to its suppression of COX-2 activity, as the selective COX-2 inhibitor but not the COX-1 inhibitor reduced embryo hatching to an extent similar to indomethacin. Our results further show that COX-2-derived PGI 2 may be the key AA metabolite required for embryo hatching. This notion is supported further by the analysis of AA metabolites: PGI 2 was the predominant metabolite generated from radiolabelled AA by the embryos. Thus, indomethacin blocks PGI 2 synthesis depriving the embryo of one of its key mediators required for its growth and hatching.
It is well known that PGI 2 plays an important role in maintaining vascular homeostasis and controlling blood cell activity. That PGI 2 has physiological functions outside the cardiovascular system was first suggested by observations made in COX-2-deficient mice (Lim et al., 1997) , which underscores the indispensable role of endometrial COX-2-derived PGI 2 in normal decidualization and receptivity. Subsequently, it has been reported that human and mouse (Melham et al., 2004) oviducts produce PGI 2 and that embryos exposed to PGI 2 analogue between 8-cell and morula stages undergo enhanced hatching (Huang et al., 2003) and possess augmented potential for implantation and live birth . Collectively, PGI 2 produced by the embryo and the oviduct acts as an autocrine/paracrine factor to enhance mouse embryo hatching, implantation and live birth.
It may be speculated that mice deficient in phopholipase A 2 , COX-2, PGIS or PGI 2 receptor may produce smaller litters than their wild-type counterparts because their embryos, lacking the autocrine/paracrine effects of PGI 2 , may have decreased hatching and consequently lower implantation potential. Phospholipase A 2 -deficient mice have smaller litters than the wild-type (Bonventre et al., 1997) . COX-2-deficient mice are sterile because they do not ovulate (Lim et al., 1997) . The litter size of PGIS- (Yokoyama et al., 2002) and PGI 2 receptor- (Murata et al., 1997 ) deficient mice has not been compared with that of the wild-types. However, it should be pointed out that breeding COX-2 heterozygous knockout mice (Morham et al., 1995) or PGI 2 receptor heterozygous knockout mice (Murata et al., 1997) produced less homozygous offspring than expected based on Mendel's law. These observations suggest that PGI 2 deficiency may compromise embryo hatching and decrease implantation potential.
Phenotypes of gene deficiency vary with the genetic backgrounds of the mice. For example, COX-2 deficiency causes sterility in C57BL/6J/129 mice (Lim et al., 1997) but subfertility in CD1 mice (Wang et al., 2004) . The diverse genetic pool of CD1 mice does not completely reverse the adverse impacts of COX-2 deficiency. As a result, COX-2-deficient CD1 mice still display significant problems in ovulation and decidualization: they have significantly smaller litters and display significantly less receptivity to transferred wild-type embryos. These observations underscore the importance of COX-2 in ovulation and decidualization. However, the potentials of hatching and implantation of COX-2-deficient embryos were not reported.
Embryo-derived PGs may have other physiological functions such as regulating the transport of embryos. Results from HPLC analysis indicate that, in addition to PGI 2 , mouse embryos also produce PGE 2 and PGF 2a . Since oviducts express receptors for PGI 2 and PGE 2 (Segi et al., 2003) , embryo-derived PGI 2 and PGE 2 may bind to these receptors, relax the muscle and regulate embryo transport.
The mechanisms by which PGI 2 enhanced embryo hatching have not been elucidated. One possible mechanism is augmented ion/water transport across the tight junction between the inner cell mass and the trophectoderm Figure 6 . COX-1, COX-2 and PGIS were expressed in mouse blastocysts. The expression of COX-1, COX-2 and PGIS was studied in all stages of embryos and unfertilized eggs. The localization of COX-1 and COX-2 was accomplished by direct immunostaining using affinity-purified COX-1 and COX-2 antibody conjugated with rhodamine; the localization of PGIS was accomplished via indirect immunostaining using affinity-purified rabbit polyclonal anti-PGIS peptide antibody and donkey anti-rabbit immunoglobulin G (IgG) conjugated with Alexa 488. Pre-absorbed PGIS antibody or fluorescein isothiocyanate-conjugated non-immune IgG (in the case of COX-1 and COX-2) were used as negative controls. COX-1 became detectable in 8-cell and later stage embryos, whereas COX-2 and PGIS became detectable in 4-cell and later stage embryos. Only the blastocysts are shown here; both the trophectoderm and the inner cell mass of blastocysts displayed immunostaining. All negative controls showed no staining (not shown). The bar is ,30 mm. (Biggers et al., 1988) . Enhanced ion/water transport into blastocysts increases the blastocoel cavity and facilitates embryo hatching (Biggers et al., 1988) . Alternatively, endogenous PGI 2 may increase embryonic cell number by decreasing cell death or increasing cell proliferation. This is supported by a recent report which showed that compared with embryo hatching in vivo, embryos hatching in vitro require more embryonic cells (Montag et al., 2000) . PGI 2 has been shown to possess anti-apoptotic properties in renal glomerular mesangial cells (Ishaque et al., 2003) and colonic epithelial cells (Cutler et al., 2003) . It is, therefore, possible that PGI 2 enhances embryo hatching by promoting cell survival.
Although there is no direct evidence for the production of PG by human embryos, it is likely that human embryos, similar to their counterparts from sheep, cattle, rabbit and mouse, also produce PGs. Transcripts of phospholipase A 2 , COX-1 and COX-2 (Wang et al., 2002) and immunoreactive COX-2 protein (Wang et al., 2002) and PGE 2 (Holmes et al., 1990) have been observed in human embryos. Embryo-derived PGs, together with oviduct-derived PGs , may augment the hatching of human embryos in a paracrine/autocrine fashion analogous to their augmentation of the hatching of mouse embryos. Therefore, the safety of nonsteroidal anti-inflammatory drugs, especially the selective COX-2 inhibitors, in women desiring pregnancy may need to be re-evaluated.
Our immunohistochemistry study shows that the trophectoderm and the inner cell mass of mouse blastocysts express COX-1, COX-2 and PGIS. This is different from a previous report based on observations of triploid human embryos which show that trophectoderm, but not inner cell mass, expresses COX-2 (Wang et al., 2002) . The discrepancy could be due to species differences or abnormal embryo development as a result of triploidy of chromosomes. Alternatively, it may be due to different methodologies used in the immunohistochemistry. We used Triton X-100 to permeate the tight junction between the trophectoderm and the inner cell mass prior to immunostaining, whereas no detergent was used in the above-mentioned study.
In summary, our results show that mouse embryos express COX-1, COX-2 and PGIS which catalyse the formation of PGI 2 , and that COX-2-derived PGI 2 plays a critical role in embryo hatching.
